Evidence map›Paper›PMID 32834946›Full record

ReviewActa pharmaceutica Sinica. B2020

Combating COVID-19 with integrated traditional Chinese and Western medicine in China.

Liqiang Ni, Lili Chen, Xia Huang, Chouping Han, Jianrong Xu, Hong Zhang, Xin Luan, Yongfang Zhao, Jianguang Xu, Weian Yuan and 1 more

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Acta pharmaceutica Sinica. B, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 80 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
80citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

80 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Trial
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

20 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Liqiang NiShanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
Lili ChenShanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
Xia HuangRuijin Hospitol, Shanghai Jiaotong University School of Medicine, Shanghai 200025, China.
Chouping HanShanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
Jianrong XuDepartment of Phamacology, Shanghai Jiaotong University School of Medicine, Shanghai 200025, China.
Hong ZhangShanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
Xin LuanShanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
Yongfang ZhaoShanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
Jianguang XuShanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
Weian YuanShuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
Hongzhuan ChenShanghai University of Traditional Chinese Medicine, Shanghai 201203, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

COVID-19, an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has spread throughout the world. China has achieved rapid containment of this highly infectious disease following the principles of early detection, early quarantine and early treatment with integrated traditional Chinese and Western medicine. The inclusion of traditional Chinese medicine (TCM) in the Chinese protocol is based on its successful historic experience in fighting against pestilence. Current findings have shown that the Chinese medicine can reduce the incidence of severe or critical events, improve clinical recovery and help alleviate symptoms such as cough or fever. To date there are over 133 ongoing registered clinical studies on TCM/integrated traditional Chinese and Western medicine. The three Chinese patent medicines (

Indexed as

COVID-19Integrated traditional Chinese and Western medicineSARS-CoV-2Traditional Chinese medicine

Identifiers

PMID32834946
PMCPMC7319939

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.